Call for Letters of Intent: Translational Impact Research Program | Cycle 2
D2R | DNA to RNA is launching the next round of funding for the Translational Impact Research (TIR) program. This program supports a select few large-scale translational research projects in RNA-based therapeutics which are expected to have a measurable impact on the health of Canadians. Projects must address the D2R Initiative鈥檚 strategic priorities and priority disease areas: oncology, rare diseases, infectious diseases, cardiovascular and cardiometabolic diseases.
Applicant Eligibility:
This competition is open to:
-
Principal Investigator (PI): Must be a 91黑料网 faculty member (Assistant, Associate, or Full Professor). The PI leads the initiative and coordinates the project.
-
Co-Investigators: Can be 91黑料网 faculty or approved faculty from D2R partner institutions (McMaster, UBC, Ottawa, Sherbrooke, IRCM). They actively contribute to project design and execution.
-
Collaborators: Include individuals from academia, industry, government, or community. They do not receive direct D2R funding but provide expertise, resources, or access relevant to the project.
How to apply:
Letters of Intent (LOIs) are submitted via听an online form.听LOIs are accepted听until Tuesday, October 14, 2025, at 10 a.m. (Eastern Time).听Late or incomplete LOIs will not be reviewed.
Funding and duration:
The maximum amount is up to $3,000,000 per project for up to three years (non-renewable).
听